Remove latest-conference
article thumbnail

The highs — and lows — of JPM 2024 you should pay attention to

STAT

To stay on top of the latest scoops and live reporting from the San Francisco conference,  join our newsletter list. JPM Week is finally drawing to a close, sending the drug industry’s many financiers scattering from San Francisco to their respective homes and ski destinations.

article thumbnail

This is the TLDR of JPM Day 1

STAT

To stay on top of the latest scoops and live reporting from the San Francisco conference, join our newsletter list. Morgan Healthcare Conference. In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout. “The lanyards” have landed!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Listen: Live! From JPM 2024

STAT

Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit. Recording from the J.P.

276
276
article thumbnail

Green shoots and cautious optimism: Insights from BIO-Europe Spring

pharmaphorum

Discover the latest insights and trends from BIO-Europe Spring conference, focusing on green shoots and cautious optimism in the industry. Learn about the latest funding opportunities and more.

115
115
article thumbnail

Listen: ESMO highlights, Roivant’s big deal, & biotech VC on the rise

STAT

Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.

280
280
article thumbnail

JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far

STAT

To stay on top of the latest scoops and live reporting from the San Francisco conference,  join our newsletter list. In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout.

article thumbnail

STAT+: Alzheimer’s researchers try out an unfamiliar sensation: optimism

STAT

SAN FRANCISCO — Scientific meetings about Alzheimer’s disease can be funereal affairs, with researchers from around the world gathering in hopes that the latest in a long line of negative clinical trials might light the path to a long-awaited success. This year was different.

363
363